Literature DB >> 22744667

A candidate gene for autoimmune myasthenia gravis.

Guida Landouré1, Melanie A Knight, Horia Stanescu, Addis A Taye, Yijun Shi, Oumarou Diallo, Janel O Johnson, Dena Hernandez, Bryan J Traynor, Leslie G Biesecker, Abdel Elkahloun, Carlo Rinaldi, Angela Vincent, Nick Willcox, Robert Kleta, Kenneth H Fischbeck, Barrington G Burnett.   

Abstract

OBJECTIVE: We sought to identify a causative mutation in a previously reported kindred with parental consanguinity and 5 of 10 siblings with adult-onset autoimmune myasthenia gravis.
METHODS: We performed genome-wide homozygosity mapping, and sequenced all known genes in the one region of extended homozygosity. Quantitative and allele-specific reverse transcriptase PCR (RT-PCR) were performed on a candidate gene to determine the RNA expression level in affected siblings and controls and the relative abundance of the wild-type and mutant alleles in a heterozygote.
RESULTS: A region of shared homozygosity at chromosome 13q13.3-13q14.11 was found in 4 affected siblings and 1 unaffected sibling. A homozygous single nucleotide variant was found in the 3'-untranslated region of the ecto-NADH oxidase 1 gene (ENOX1). No other variants likely to be pathogenic were found in genes in this region or elsewhere. The ENOX1 sequence variant was not found in 764 controls. Quantitative RT-PCR showed that expression of ENOX1 decreased to about 20% of normal levels in lymphoblastoid cells from individuals homozygous for the variant and to about 50% in 2 unaffected heterozygotes. Allele-specific RT-PCR showed a 55%-60% reduction in the level of the variant transcript in heterozygous cells due to reduced mRNA stability.
CONCLUSION: These results indicate that this sequence variant in ENOX1 may contribute to the familial autoimmune myasthenia in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744667      PMCID: PMC3400092          DOI: 10.1212/WNL.0b013e318260cbd0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

2.  Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees.

Authors:  E Sobel; H Sengul; D E Weeks
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

3.  Familial autoimmune myastenia gravis: four patients involving three generations.

Authors:  R A Marrie; D J Sahlas; G M Bray
Journal:  Can J Neurol Sci       Date:  2000-11       Impact factor: 2.104

4.  The clinical study and HLA genotyping of 112 familial myasthenia gravis patients.

Authors:  B Bu; M Yang; J Xu; F Gong; X Jiang; X Nie
Journal:  J Tongji Med Univ       Date:  1999

5.  Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface.

Authors:  Pin-Ju Chueh; Chinpal Kim; NaMi Cho; Dorothy M Morré; D James Morré
Journal:  Biochemistry       Date:  2002-03-19       Impact factor: 3.162

6.  Familial autoimmune myasthenia gravis.

Authors:  J H Tan; K H Ho
Journal:  Singapore Med J       Date:  2001-04       Impact factor: 1.858

7.  Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.

Authors:  R Bortell; J Moss; R C McKenna; M R Rigby; D Niedzwiecki; L A Stevens; W A Patton; J P Mordes; D L Greiner; A A Rossini
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

8.  Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis.

Authors:  M Giraud; B Eymard; C Tranchant; P Gajdos; H-J Garchon
Journal:  Genes Immun       Date:  2004-01       Impact factor: 2.676

9.  Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients.

Authors:  A Szobor
Journal:  Acta Med Hung       Date:  1989

10.  Familial autoimmune myasthenia gravis.

Authors:  J Bergoffen; C M Zmijewski; K H Fischbeck
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

View more
  2 in total

1.  Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.

Authors:  Guida Landouré; Peng-Peng Zhu; Charles M Lourenço; Janel O Johnson; Camilo Toro; Katherine V Bricceno; Carlo Rinaldi; Katherine G Meilleur; Modibo Sangaré; Oumarou Diallo; Tyler M Pierson; Hiroyuki Ishiura; Shoji Tsuji; Nichole Hein; John K Fink; Marion Stoll; Garth Nicholson; Michael A Gonzalez; Fiorella Speziani; Alexandra Dürr; Giovanni Stevanin; Leslie G Biesecker; John Accardi; Dennis M D Landis; William A Gahl; Bryan J Traynor; Wilson Marques; Stephan Züchner; Craig Blackstone; Kenneth H Fischbeck; Barrington G Burnett
Journal:  Hum Mutat       Date:  2013-08-12       Impact factor: 4.878

Review 2.  Functional defect in regulatory T cells in myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Julie Rowin; Qin Li Jiang; Jian Rong Sheng; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.